Close Menu

InformedDNA

The financing follows InformedDNA's signing of definitive agreements to receive growth capital investments with a number of investment groups.

InformedDNA's network of remote counselors will augment the AI-driven chatbots offered by OptraHealth's automated GeneFax platform.

Few Eyebrows Up

Time reports that some experts have raised concerns about 23andMe's new direct-to-consumer pharmacogenetic tests.

The companies have launched a center that offers consulting and management specifically for genomically targeted or precision medicine trials.

The companies are creating a new center that will offer support services to biopharmaceutical companies, CROs, and others in designing genetically informed clinical trials.

The company will now offer free genetic testing to patients at risk for acute hepatic porphyrias, a class of diseases for which it is developing a treatment.

The companies are working together to help insurers reduce wasteful spending and spur use of medically necessary tests. 

Cigna worked with InformedDNA to come up with scenarios under which it would cover whole-exome sequencing, although it still considers whole-genome analysis investigational.

A new study finds that three dimensional facial scans may be able to aid in diagnosing rare genetic diseases.

The Lancet and the New England Journal of Medicine have retracted two COVID-19 papers due to concerns about the data used in their analyses.

Lawmakers plan to introduce a bill that aims to prevent the theft of US-funded research, according to the Wall Street Journal.

In Science this week: analysis of ancient Caribbean islanders' genomes suggests at least three waves of migration into the region,  DNA barcoding of microbial spores, and more.